Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis

被引：60
|
作者：
Boissinot, Marjorie [1 ]
Lippert, Eric [1 ]
Girodon, Francois [1 ]
Dobo, Irene [1 ]
Fouassier, Marc [1 ]
Masliah, Claude [1 ]
Praloran, Vincent [1 ]
Hermouet, Sylvie [1 ]
机构：
[1] CHU Nantes, Lab Hematol, Inst Biol, F-44093 Nantes, France
来源：
BLOOD | 2006年 / 108卷 / 09期
关键词：
D O I：
10.1182/blood-2006-05-021527
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3223 / 3224
页数：2
相关论文
共 50 条
  • [41] JAK2V617F mutation in patients with arterial thrombosis in the absence of overt myeloproliferative disease
    Dentali, F.
    Squizzato, A.
    Appio, L.
    Brivio, L.
    Ageno, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (04) : 722 - 725
  • [42] Relevance of the JAK2V617F mutation in patients with deep vein thrombosis of the leg
    Mandy N. Lauw
    Erik W. N. Bus
    Alexander F. Y. van Wulfften Palthe
    Michiel Coppens
    Christa H. Homburg
    Saskia Middeldorp
    C. Ellen van der Schoot
    Harry R. Koene
    Bart J. Biemond
    Annals of Hematology, 2012, 91 : 103 - 107
  • [43] Relevance of the JAK2V617F mutation in patients with deep vein thrombosis of the leg
    Lauw, Mandy N.
    Bus, Erik W. N.
    Palthe, Alexander F. Y. van Wulfften
    Coppens, Michiel
    Homburg, Christa H.
    Middeldorp, Saskia
    van der Schoot, C. Ellen
    Koene, Harry R.
    Biemond, Bart J.
    ANNALS OF HEMATOLOGY, 2012, 91 (01) : 103 - 107
  • [44] The JAK2-V617F mutation is a risk factor for venous but not for arterial thrombosis in essential thrombocythemia
    Gisslinger, H.
    Esterbauer, H.
    Kralovics, R.
    Gisslinger, B.
    Kees, M.
    Woerl, T.
    Muellauer, L.
    Wiesbauer, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 244 - 244
  • [45] Lack of Association Between the 46/1 JAK2 Haplotype and the Presence of JAK2V617F Mutation In Splanchnic Vein Thrombosis Patients
    Kouroupi, Eirini G.
    Cassinat, Bruno
    Plessier, Aurelie
    Bellucci, Sylvia
    Chomienne, Christine
    Granchamp, Bernard
    Valla, Dominique
    Kiladjian, Jean-Jacques
    BLOOD, 2010, 116 (21) : 1677 - 1677
  • [46] Bone marrow mesenchymal stromal cells of patients with myeloproliferative disorders do not carry the JAK2-V617F mutation
    Mercier, Francois
    Monczak, Yury
    Francois, Moira
    Prchal, Jaroslav
    Galipeau, Jacques
    EXPERIMENTAL HEMATOLOGY, 2009, 37 (03) : 416 - 420
  • [47] JAK2 V617F is specifically associated with idiopathic splanchnic vein thrombosis
    Regina, S.
    Herault, O.
    D'Alteroche, L.
    Binet, C.
    Gruel, Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (04) : 859 - 861
  • [48] Up-front Screening for the JAK2 V617F Mutation in Patients Presenting with Thrombosis other than Splanchnic Vein Thrombosis
    Langabeer, Stephen E.
    CLINICAL LABORATORY, 2015, 61 (11) : 1813 - 1814
  • [49] Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with budd-chiari syndrome and/or portal vein thrombosis
    Karakose, Suleyman
    Oruc, Nevin
    Zengin, Melia
    Akarca, Ulus Salih
    Ersoz, Galip
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2015, 26 (01): : 42 - 48
  • [50] The JAK2V617F mutation and thrombosis
    Austin, S. K.
    Lambert, J. R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (03) : 307 - 320
12345